Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Squire

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
European Heart Journal|February 17, 2017
Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) StudyAnvesha Singh, John P Greenwood, Colin Berry, et al.
Journal of the American College of Cardiology|January 7, 2017
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network StudyLeong L Ng, Iain B Squire, Donald J L Jones, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Radiology. Cardiothoracic Imaging|October 2, 2025
Cardiovascular MRI Feature-Tracking Strain Rate for Assessment of Diastolic FunctionJian L Yeo, Abhishek Dattani, Aseel Alfuhied, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 13, 2023
The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD ReadmissionsConstantinos Kallis, Amit Kaura, Nathan A Samuel, et al.
BMC Cardiovascular Disorders|February 7, 2024
Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkersAbhishek Dattani, Emer M Brady, Prathap Kanagala, et al.
European Heart Journal|June 30, 2016
Geographic variations in the PARADIGM-HF heart failure trialSøren Lund Kristensen, Felipe Martinez, Pardeep S Jhund, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
European Heart Journal|February 17, 2017
Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) StudyAnvesha Singh, John P Greenwood, Colin Berry, et al.
Journal of the American College of Cardiology|January 7, 2017
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network StudyLeong L Ng, Iain B Squire, Donald J L Jones, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Radiology. Cardiothoracic Imaging|October 2, 2025
Cardiovascular MRI Feature-Tracking Strain Rate for Assessment of Diastolic FunctionJian L Yeo, Abhishek Dattani, Aseel Alfuhied, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 13, 2023
The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD ReadmissionsConstantinos Kallis, Amit Kaura, Nathan A Samuel, et al.
BMC Cardiovascular Disorders|February 7, 2024
Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkersAbhishek Dattani, Emer M Brady, Prathap Kanagala, et al.
European Heart Journal|June 30, 2016
Geographic variations in the PARADIGM-HF heart failure trialSøren Lund Kristensen, Felipe Martinez, Pardeep S Jhund, et al.
Pageof 30